Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 5,513
- Institution
- Lunenfeld-Tanenbaum Research Institute
External Links
Identifiers
- ORCID
- 0000-0002-0041-1876
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.